Englewood, New Jersey Clinical Trials

A listing of Englewood, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 201 clinical trials
Community-based Implementation of Online EmReg

This is a hybrid type III implementation-effectiveness trial; this study design blends elements of implementation and clinical effectiveness research, with the primary aim of determining the utility of an implementation strategy and a secondary aim of assessing clinical outcomes associated with the implementation trial. Consistent with best practices for this …

Accepts healthy volunteers
Icahn School of Medicine at Mount Sinai
 (7.3 away) Contact site
  • 0 views
  • 11 Jul, 2023
  • 1 location
Asthma 2  

Asthma 2

P Site 2
 (6.5 away)
  • 0 views
  • 16 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Columbia University Irving Medical Center / NYPH
 (4.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

metastatic cancer
metastatic disease
metastasis
cancer
metastatic castration-resistant prostate cancer
Memorial Sloan Kettering Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Lorenc Aesthetic Plastic Surgery Center
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

myeloid leukemia
acute myeloid leukemia
refractory acute myeloid leukemia (aml)
refractory aml
myelodysplastic syndromes
Memorial Sloan-Kettering Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
TKR With and Without the Use of Intra-operative Sensing

The purpose of this study is to determine if there is a difference in clinical outcomes after total knee replacement (TKR) performed with traditional ligament balancing compared to use of intraoperative sensing technology (IOS) to balance ligaments. IOS is used to send real time information to a monitor within the …

total knee replacement
osteoarthritis
Hospital for Special Surgery
 (8.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

coagulation disorder
seizures
platelet count
glioma
diffuse intrinsic pontine glioma
Columbia University Irving Medical Center
 (4.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

hysterectomy
cancer
metastatic lung adenocarcinoma
bilateral oophorectomy
non-small cell lung cancer
Icahn School of Medicine at Mount Sinai
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

ovarian cancer
peritoneal cancer
muga scan
ATR
platelet count
Memorial Sloan-Kettering Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations